Prosecution Insights
Last updated: October 25, 2026

Femtherapeutics Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Femtherapeutics Inc. is currently focused on the Medical Devices & Mechanical Engineering technology area, where the data shows 1 pending office action. This specific level of activity suggests that the company is pursuing a targeted patent strategy. For practitioners, this means the current prosecution efforts are concentrated on a specific set of claims within the medical device sector.

The administrative profile of this portfolio includes 1 distinct examiner and 1 distinct art unit. This ratio between the pending action and the examiner indicates a direct line of communication with the patent office. Because the prosecution is limited to 1 distinct art unit, the applicant only needs to navigate the specific procedural requirements of that particular department.

BECCIA, CHRISTOPHER J is the busiest examiner for Femtherapeutics Inc., with 1 busiest examiner pending action currently assigned. As this examiner is responsible for the only pending matter, the outcome of the portfolio's current prosecution depends on the interaction with this individual. The applicant can focus their resources on addressing the specific feedback from this examiner to advance their interests in the Medical Devices & Mechanical Engineering field.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§102 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BECCIA, CHRISTOPHER J 1 83.5% +14.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18862715 GYNECOLOGICAL PROTHETIC WITH ANCHOR MEMBERS AND EXPANDABLE CONNECTING LINKS, AND METHOD FOR CUSTOM-DESIGNNG THE SAME BECCIA, CHRISTOPHER J —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18862715 GYNECOLOGICAL PROTHETIC WITH ANCHOR MEMBERS AND EXPANDABLE CONNECTING LINKS, AND METHOD FOR CUSTOM-DESIGNNG THE SAME BECCIA, CHRISTOPHER J —

Top Art Units

Art UnitApps
3775 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18862715 GYNECOLOGICAL PROTHETIC WITH ANCHOR MEMBERS AND EXPANDABLE CONNECTING LINKS, AND METHOD FOR CUSTOM-DESIGNNG THE SAME BECCIA, CHRISTOPHER J 3775 §102 Non-Final OA — Pending Nov 04, 2024

Managing Femtherapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Femtherapeutics Inc. have?

Femtherapeutics Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Femtherapeutics Inc. applications?

Christopher J Beccia has the most, with 1 of Femtherapeutics Inc.'s pending office actions.

What technology area are Femtherapeutics Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month